Literature DB >> 14120168

CROHN'S DISEASE.

H EDWARDS.   

Abstract

Keywords:  ADOLESCENCE; CHILD; COLITIS, ULCERATIVE; ENTERITIS, REGIONAL; EXPERIMENTAL LAB STUDY; GUINEA PIGS; PATHOLOGY; PSYCHOSOMATIC MEDICINE; RADIOTHERAPY; STEROIDS; SURGERY, OPERATIVE

Mesh：

Substances：

Year:  1964        PMID： 14120168

Source DB:  PubMed          Journal:  J R Coll Surg Edinb        ISSN： 0035-8835


× No keyword cloud information.
  8 in total

1.  An epidermilogical survey of Crohn's disease in Northern Ireland.

Authors:  W G Humphreys
Journal:  Proc R Soc Med       Date:  1975-09

2.  Corticosteroids and corticotrophin in the treatment of Crohn's disease.

Authors:  J H Jones; J E Lennard-Jones
Journal:  Gut       Date:  1966-04       Impact factor: 23.059

3.  Crohn's disease and carcinoma of colon.

Authors:  A D Perrett; S C Truelove; G R Massarella
Journal:  Br Med J       Date:  1968-05-25

4.  Free perforation in regional enteritis.

Authors:  J Kyle; T Caridis; T Duncan; S W Ewen
Journal:  Am J Dig Dis       Date:  1968-03

5.  Intestinal cancer risk in Crohn's disease: a meta-analysis.

Authors:  Mike Georg Laukoetter; Rudolf Mennigen; C Mareike Hannig; Nani Osada; Emile Rijcken; Thorsten Vowinkel; Christian F Krieglstein; Norbert Senninger; Christoph Anthoni; Matthias Bruewer
Journal:  J Gastrointest Surg       Date:  2010-12-09       Impact factor: 3.452

6.  Intestinal cancer in patients with Crohn's disease.

Authors:  Sabine Kersting; Matthias Bruewer; Mike G Laukoetter; Emile M Rijcken; Rudolf Mennigen; Horst Buerger; Norbert Senninger; Christian F Krieglstein
Journal:  Int J Colorectal Dis       Date:  2006-07-18       Impact factor: 2.571

7.  Recurrence of Crohn's disease after primary excisional surgery.

Authors:  F T De Dombal; I Burton; J C Goligher
Journal:  Gut       Date:  1971-07       Impact factor: 23.059

8.  Occurrence and outcome after primary treatment of anal fistulae in Crohn's disease.

Authors:  G Hellers; O Bergstrand; S Ewerth; B Holmström
Journal:  Gut       Date:  1980-06       Impact factor: 23.059
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.